Arrowhead Pharmaceuticals: Q2 Earnings Insights

Arrowhead Pharmaceuticals ARWR reported its Q2 earnings results on Tuesday, May 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Arrowhead Pharmaceuticals beat estimated earnings by 612.5%, reporting an EPS of $0.41 versus an estimate of $-0.08.

Revenue was up $118.99 million from the same period last year.

Last quarter the company missed on EPS by $0.15 which was followed by a 6.92% drop in the share price the next day.

Here's a look at Arrowhead Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.45	-0.10	-0.20	-0.13
EPS Actual	-0.60	-0.61	-0.29	-0.26
Revenue Estimate	51.04M	56.77M	37.52M	37.70M
Revenue Actual	27.44M	38.28M	45.89M	32.81M

To track all earnings releases for Arrowhead Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar